ACHAOGEN

Achaogen is a clinical stage biopharmaceutical company focused on the discovery and development of broad-spectrum antibiotics to treat multi-drug resistant bacterial infections. The company's most advanced drug candidate, ACHN-490, has demonstrated a positive safety and dosing profile in Phase 1 clinical testing and displayed broad spectrum efficacy in preclinical studies against systemic infections caused by multi-drug resistant (MDR) Gram-negative bacteria (e.g., E. coli, K. pneumoniae, and P. aeruginosa) and MRSA. In addition, the company is pursuing preclinical programs in several other areas of interest to combat the global emergence of bacterial resistance.

#People #Financial #Website #More

ACHAOGEN

Social Links:

Facebook

Linkedin

Twitter

Industry:

Biotechnology Health Care Medical

Founded:

2004-01-01

Address:

South San Francisco, California, United States

Country:

United States

Website Url:

http://www.achaogen.com

Total Employee:

1+

Status:

Closed

Contact:

(650) 800-3636

Email Addresses:

[email protected]

Total Funding:

178.66 M USD

Technology used in webpage:

Apache IPv6 Pound Sterling Japanese Yen Comcast Symantec Secure Site ATT Citrix NetScaler Register.com DNS Confluence Networks

Current Advisors List

george-drusano_image

George Drusano Advisor @ Achaogen
Advisor

scott-m-rocklage_image

Scott M. Rocklage Board Chairman @ Achaogen
Board_member

kush-parmar_image

Kush Parmar Board Observer @ Achaogen
Board_observer
2010-01-01

bryan-roberts_image

Bryan Roberts Member of the Board of Directors @ Achaogen
Board_member

christopher-t-walsh_image

Christopher T. Walsh Board of Directors @ Achaogen
Board_member

robert-j-more_image

Robert J. More Board of Directors @ Achaogen
Board_member

camille-samuels_image

Camille Samuels Member of the Board of Directors @ Achaogen
Board_member

Current Employees Featured

janet-dorling_image

Janet Dorling
Janet Dorling Chief Commercial Officer @ Achaogen
Chief Commercial Officer

zeryn-sarpangal_image

Zeryn Sarpangal
Zeryn Sarpangal Chief Financial Officer @ Achaogen
Chief Financial Officer
2018-01-01

liz-bhatt_image

Liz Bhatt
Liz Bhatt Chief Operating Officer @ Achaogen
Chief Operating Officer
2018-07-01

blake-wise_image

Blake Wise
Blake Wise Chief Executive Officer @ Achaogen
Chief Executive Officer
2018-01-01

kenneth-hillan_image

Kenneth Hillan
Kenneth Hillan President & Chief Executive Officer @ Achaogen
President & Chief Executive Officer
2011-01-01

Founder

kevin-judice_image

Kevin Judice

nathaniel-david_image

Nathaniel David

Stock Details

Company's stock symbol is NASDAQ:AKAO

Investors List

carb-x_image

CARB-X

CARB-X investment in Grant - Achaogen

carb-x_image

CARB-X

CARB-X investment in Grant - Achaogen

domain-associates_image

Domain Associates

Domain Associates investment in Series D - Achaogen

venrock_image

Venrock

Venrock investment in Series D - Achaogen

alta-partners_image

Alta Partners

Alta Partners investment in Series D - Achaogen

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series D - Achaogen

5am-ventures_image

5AM Ventures

5AM Ventures investment in Series D - Achaogen

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series D - Achaogen

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series D - Achaogen

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series C - Achaogen

Official Site Inspections

http://www.achaogen.com

Host Informations
Whois Informations

Loading ...

More informations about "Achaogen" on Search Engine